Second Stock Today

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>SS</div>
Second Sight is selling at 1.02 as of the 5th of June 2020; that is 2.00 percent increase since the beginning of the trading day. The stock's lowest day price was 0.9205. Second Sight has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 30 days. Equity ratings for Second Sight Medical are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 7th of March 2020 and ending today, the 5th of June 2020. Click here to learn more.
Analyze Filter   Report: 10th of June 2020

   Performance
0 100 

   Odds of Distress
94  

Second Sight Profile

Upcoming quarterly report is expected on 10th of June 2020. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. The company was founded in 1998 and is headquartered in Sylmar, California. Second Sight operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 112 people. more on Second Sight
Second Sight Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Second Sight Medical SEC Filings
Second Sight SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameSecond Sight Medical
Older SymbolEYESW
President CEO, DirectorJonathan McGuireView All
Thematic Classification
Currently Active Investing Idea
  Medical Equipment
View All
Average Analyst Recommendation
Strong Buy1 Opinion
Piotroski F Score
Academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Second Sight Medical financial position. Scores of 8 and 9 are usually clasified strong value stocks whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares15.6 M14.7 M
Notably Up
Increasing
Slightly volatile
Weighted Average Shares Diluted15.9 M14.7 M
Significantly Up
Increasing
Slightly volatile
Net Cash Flow from Operations(27.6 M)(27.6 M)
Slightly Down
Decreasing
Slightly volatile
Total Assets28.2 M16.6 M
Way Up
Increasing
Stable
Total LiabilitiesM9.3 M
Sufficiently Down
Decreasing
Slightly volatile
Current Assets26.8 M13.1 M
Way Up
Increasing
Stable
Current LiabilitiesMM
Fairly Up
Increasing
Slightly volatile
Total Debt2.6 M2.3 M
Significantly Up
Decreasing
Slightly volatile
Return on Average Assets(0.0131)(1.215)
Way Down
Increasing
Very volatile
Gross Margin0.39170.363
Significantly Up
Increasing
Slightly volatile
Asset Turnover0.12520.122
Fairly Up
Increasing
Slightly volatile
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Second Sight available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Cautious HoldUnder Valued
Financial Strength
Second Sight financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Second Sight success along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
  Operating Cash Flow
Second Sight Medical (EYES) is traded on BATS Exchange in USA. It is located in 12744 San Fernando Road, Suite 400, Sylmar, CA 91342, United States and employs 112 people. Second Sight Medical was previously known as Second Sight Medical and was traded on BATS Exchange under the symbol EYESW. Second Sight is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with current market capitalization of 37.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Second Sight's market, we take the total number of it shares issued and multiply it by the Second Sight's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Second Sight Medical conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 15.6 M outstanding shares of which 774.55 K shares are currently shorted by private and institutional investors with about 1.56 trading days to cover. Second Sight Medi currently holds about 11.33 M in cash with (27.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of -3.5078.
Check Second Sight Probability Of Bankruptcy

Ownership Allocation (%)

Second Stock Price Odds Analysis

Odds Down 1.02HorizonTargetOdds Up 1.02
22.84%30 days
 1.02 
77.11%
Based on normal probability distribution, the odds of Second Sight to move above current price in 30 days from now is about 77.11 (This Second Sight Medical probability density function shows the probability of Second Sight Stock to fall within a particular range of prices over 30 days) .

Second Sight Income Statement Over Time

Second Sight Medical Income Statement is one of the three primary financial statements used for reporting Second's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Second Sight Medical revenue and expense. Second Sight Income Statement primarily focuses on the company's revenues and expenses during a particular period. Second Sight Direct Expenses is relatively stable at the moment as compared to the last year. Second Sight reported last year Direct Expenses of 2.15 Million. As of 06/05/2020, Cost of Revenue is likely to grow to about 3.3 M, while Earning Before Interest and Taxes EBIT is likely to drop (36.2 M). View More Fundamentals
Consolidated Income    Interest Expense    Net Income    

Second Stock Against Markets

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Second Sight Upcoming and Recent Events

Second Sight Company Earnings Announcements Dates

Upcoming Quarterly Report10th of June 2020
Next Earnings Report4th of August 2020
Next Fiscal Quarter End31st of March 2020
Next Fiscal Year End18th of March 2021
Last Quarter Report31st of December 2019
Last Earning Anouncement31st of March 2019

Second Sight Corporate Filings

Second Sight SEC Reporting

Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
Other Events. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
Unclassified Corporate Event
View
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Unclassified Corporate Event
View

Second Sight Corporate Directors

Gregg Williams Independent Director
William Link Independent Director
James Miller Director - Manufacturing
Continue to Investing Opportunities. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page